Related Experiment Video
Updated: Feb 16, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.2K
Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study
Walid Bouthour1,2, Jennifer Wegrzyk1, Shahan Momjian3
1Department of Neurology, Geneva University Hospital, Geneva, Switzerland.
Movement Disorders : Official Journal of the Movement Disorder Society
|December 22, 2017
Summary
Shortening pulse widths in subthalamic nucleus deep brain stimulation for Parkinson's disease significantly widens the therapeutic window. This approach improves stimulation efficiency without increasing electrical charge for clinical benefit.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder.
- Subthalamic nucleus deep brain stimulation (STN-DBS) is a common treatment for PD.
- Optimizing STN-DBS parameters is crucial for maximizing therapeutic benefits.
Purpose of the Study:
- To investigate the acute effects of varying short pulse widths on the therapeutic window in STN-DBS for Parkinson's disease.
- To determine if shorter pulse widths enhance stimulation efficiency.
Main Methods:
- A randomized, double-blind study involving 10 PD patients with STN-DBS.
- Patients received stimulation at various pulse widths (10-50 µs) compared to a 60-µs baseline.
- Therapeutic window and charge per pulse were measured as primary and secondary outcomes, respectively.
Main Results:
- A statistically significant widening of the therapeutic window was observed with shorter pulse widths (r = -0.45; P < 0.001).
- Reduced charge per pulse was achieved with shorter pulse widths (P < 0.05), indicating improved stimulation efficiency.
Conclusions:
- Shorter pulse widths effectively widen the therapeutic window in STN-DBS for Parkinson's disease.
- This optimization can be achieved without increasing the electrical charge for comparable clinical outcomes.
- Findings suggest potential for improved STN-DBS efficacy and patient management.

